Pharmacological Treatments Available for Immune-Checkpoint-Inhibitor-Induced Colitis

Immune checkpoint inhibitor treatment has shown revolutionary therapeutic effects in various carcinomas. However, immune-related adverse events (irAE) following this treatment can sometimes lead to treatment discontinuation. One such frequently encountered adverse event is immune-related colitis (ir...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohwada, Sae, Ishigami, Keisuke, Akutsu, Noriyuki, Nakase, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219666/
https://www.ncbi.nlm.nih.gov/pubmed/35740355
http://dx.doi.org/10.3390/biomedicines10061334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219666/
https://www.ncbi.nlm.nih.gov/pubmed/35740355
http://dx.doi.org/10.3390/biomedicines10061334

Ejemplares similares